• Talk Library
  • Accelerator Program
  • Design Sprint
  • About Us
    • Our Team
    • Diversity Statement
  • Subscribe
  • Upcoming Live Talk
  • Talk Library
  • Accelerator Program
  • Design Sprint
  • About Us
    • Our Team
    • Diversity Statement
  • Subscribe
  • Upcoming Live Talk

Ethical Considerations of Healthcare AI And XR Technology


 Duration: 1 hr

Watch Now
Share the Talk

Talk Overview

This presentation, "Ethical Considerations of Healthcare AI and XR Technology," explores the evolving landscape of healthcare technology, emphasizing the significant role artificial intelligence (AI) plays in addressing contemporary healthcare challenges. The presentation outlines the urgent need to innovate healthcare approaches due to demographic shifts, aging populations, and the increasing prevalence of chronic and mental health conditions. It highlights how advancements in AI and digital health technologies, such as wearable sensors, digital therapeutics, machine learning, and XR systems, transform healthcare delivery by enabling more personalized, data-driven, and proactive care.

Key ethical considerations associated with healthcare AI are central to the discussion. These include patient privacy and data protection, ensuring transparency and explainability of AI systems, and mitigating biases in AI algorithms to promote fairness and equity. The presentation stresses the importance of maintaining human oversight in AI-driven healthcare to preserve the doctor-patient relationship and prevent over-reliance on AI systems. Additionally, it underscores the need for rigorous testing, validation, and continuous monitoring of AI technologies to ensure their safety, efficacy, and trustworthiness.

The potential societal impacts of AI in healthcare are also discussed, including changes in medical education, the evolving role of clinicians, and the broader implications for healthcare employment and resource allocation. The presentation highlights the necessity of a coordinated effort among federal agencies, such as the NIH, DoD, and VA, to organize and digitize healthcare datasets for AI research, thereby enhancing diagnostic, treatment, and disease management capabilities.

Overall, Walter Greenleaf's presentation advocates for a careful, ethically guided approach to integrating AI into healthcare, balancing the drive for innovation with the need to protect patient rights, ensure fairness, and maintain the integrity of healthcare systems. The goal is to develop AI systems that are technologically advanced and aligned with ethical principles, ensuring they contribute positively to healthcare outcomes and public trust.

Speakers

Walter Greenleaf, Ph.D.
Behavioral Neuroscientist, Stanford University
Bio

Walter Greenleaf, Ph.D.

Behavioral Neuroscientist, Stanford University

Walter Greenleaf is a neuroscientist and a medical technology developer at Stanford University. With over three decades of experience, Walter is a leading authority in digital medicine and medical virtual reality technology.

Research Focus: Walter’s current research focus is on developing computer-supported clinical products, with a specific emphasis on applying virtual reality and digital health technology to address difficult problems in behavioral and physical medicine, such as Post-traumatic Stress, Anxiety Disorders, Depression, Stroke, Addictions, and Autism Spectrum Disorder. He has served as the Principal Investigator for research projects funded by the NIH and NASA.

Academic Positions: Walter is a Visiting Scholar at Stanford University’s Virtual Human Interaction Lab and an Advisor to the Stanford University Wearable Electronics (eWear) Program. He previously served as the Director of the Mind Division at the Stanford Center on Longevity, where his focus was on age-related changes in cognition.

Corporate Management: Walter founded and served as CEO for Greenleaf Medical Systems, a medical product development company; InWorld Solutions, a company specializing in the therapeutic use of virtual worlds for behavioral health care; and Virtually Better, a company that develops virtual environments for the treatment of phobias, anxiety disorders, and PTSD. Walter was Senior Vice President of Strategic & Corp. Affairs to MindMaze and founding Chief Science Officer for Pear Therapeutics, a pioneering company in SaMD (Software As Medical Device). He is currently working with Interaxon as Chief Science Officer.

Current Board Positions: Walter serves on the Board of Directors for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship; for Cognitive Leap, a company that develops mental health solutions for children; and for Sine Wave, the developer of Sine Space, a multi-user online Unity 3D-based virtual world platform.

Advisory Board Positions: In addition to his research at Stanford University, Walter is the business, technology, and neuroscience advisor to several medical product companies, investment groups, and accelerator/incubator programs.

Moderators

Julie LeMoine Ph.D.
Asst. Professor, Neurobehavioral Technology, UMass Chan Medical School
LinkedIn

Organization(s)

Stanford Virtual Human Interaction Lab

Interested in Donating?

Tax-deductible contributions help pay operating expenses, curriculum development, and fielding the faculty.

Donate Now

Secured by PayPal Logo

About

MedVR is produced in partnership with Grassroots Developer Education, Inc., a 501(c)(3) non-profit.

Useful Links

  • Talks Library
  • Accelerator Program
  • Become A Speaker

Let's Connect

Email Icon team@medvr.io

© Copyright, medVR 2024. All rights reserved.

  • Facebook Logo
  • Twitter Logo
  • Instagram Logo
  • LinkedIn Logo
  • YouTube Logo